Concepedia

Xuexiang Du

XD

Statistics

Publications

13

Citations

1.2K

H-Index

13

Active since

2012

Affiliations

University of Maryland, Baltimore(Current)

OncoImmune (United States)

University of Chinese Academy of Sciences

Institute of Biophysics

Shandong University

Xuexiang Du is an author at University of Maryland, Baltimore specializing in immunology, oncology, and cancer immunotherapy.

Publications per year

2012–2023

13

Publications

13

A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy

Xuexiang Du, Fei Tang, Mingyue Liu et al. · Cell Research · 2018 · 246 citations · Full text

Life Sciences, Immunology, Oncology +17

Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype

Meng Xu, Mingyue Liu, Xuexiang Du et al. · The Journal of Immunology · 2015 · 140 citations

Medicine, Immunology, Oncology +17

Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues

Christopher M. Bailey, Yan Liu, Mingyue Liu et al. · Journal of Clinical Investigation · 2022 · 140 citations · Full text

Medicine, Immunology, Oncology +17

Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice

Xuexiang Du, Mingyue Liu, Juanjuan Su et al. · Cell Research · 2018 · 130 citations · Full text

Medicine, Immunology, Oncology +17

Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy

Yan Zhang, Xuexiang Du, Mingyue Liu et al. · Cell Research · 2019 · 125 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 13